EMV Capital advises on a restructuring and investment in Vortex Biotech Holdings. Appointment of new Vortex CEO to drive growth.
London, UK, 16th August 2022 – International venture capital investor and adviser, EMV Capital Ltd (EMV Capital), is pleased to announce that it has advised on the restructuring and investment in Vortex Biotech Holdings, a leader in the oncology liquid biopsy market. The company also appointed industry veteran Paul Jones to drive growth. EMV Capital advised […]